The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 29, 2022

Filed:

Feb. 18, 2016
Applicant:

Enlivex Therapeutics Rdo Ltd, Nes-Ziona, IL;

Inventors:

Shai Novik, Ramat Hasharon, IL;

Dror Mevorach, Jerusalem, IL;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0783 (2010.01); A01K 67/027 (2006.01); A61P 37/06 (2006.01); A61K 35/17 (2015.01); A61K 35/00 (2006.01); A61K 35/12 (2015.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0638 (2013.01); A01K 67/0271 (2013.01); A61K 35/17 (2013.01); A61P 37/06 (2018.01); A01K 2227/105 (2013.01); A01K 2267/0331 (2013.01); A61K 35/00 (2013.01); A61K 2035/122 (2013.01); A61K 2035/124 (2013.01); C12N 2502/1114 (2013.01); C12N 2502/30 (2013.01); C12N 2510/00 (2013.01); G01N 33/6863 (2013.01); Y02A 50/30 (2018.01);
Abstract

Compositions disclosed herein, and methods of use thereof included those for inhibiting or reducing the incidence of cytokine release syndrome or cytokine storm in a subject undergoing CAR T-cell therapy, wherein the subjects are administered compositions including apoptotic cells or apoptotic cell supernatants. In certain instances compositions and methods of use thereof disclosed herein do not reduce the efficacy of the CAR T-cell cancer therapy. Disclosed herein are also compositions and methods of use thereof for decreasing or inhibiting cytokine production in a subject experiencing cytokine release syndrome or cytokine storm including administration of a composition including apoptotic cells or an apoptotic cell supernatant.


Find Patent Forward Citations

Loading…